T.Man Pharmaceutical PCL (BKK: TMAN)
Thailand
· Delayed Price · Currency is THB
14.00
+0.10 (0.72%)
Dec 20, 2024, 10:00 AM ICT
T.Man Pharmaceutical PCL Balance Sheet
Financials in millions THB. Fiscal year is January - December.
Millions THB. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Cash & Equivalents | 105.5 | 348.04 | 307.17 | 22.19 | 66.9 |
Cash & Short-Term Investments | 105.5 | 348.04 | 307.17 | 22.19 | 66.9 |
Cash Growth | -64.36% | 13.30% | 1284.31% | -66.83% | - |
Accounts Receivable | 535.23 | 577.79 | 507.27 | 256.08 | 206.77 |
Other Receivables | 30.95 | 38.75 | 21.37 | 23.94 | 8.08 |
Receivables | 566.18 | 616.54 | 528.64 | 280.02 | 214.84 |
Inventory | 540.42 | 481.82 | 357.96 | 308.9 | 410.68 |
Other Current Assets | 6.21 | 4.99 | 32.2 | 4.21 | 7.25 |
Total Current Assets | 1,218 | 1,451 | 1,226 | 615.32 | 699.66 |
Property, Plant & Equipment | 1,128 | 1,048 | 930.41 | 742.63 | 724.85 |
Long-Term Investments | - | - | - | - | 5 |
Other Intangible Assets | 33.44 | 25.69 | 12.56 | 1.23 | 0.27 |
Long-Term Deferred Tax Assets | 36.47 | 38.89 | 40.69 | - | - |
Other Long-Term Assets | 64.5 | 63.18 | 68.24 | 199.02 | 171.13 |
Total Assets | 2,481 | 2,627 | 2,278 | 1,558 | 1,601 |
Accounts Payable | 345.58 | 331.91 | 333.08 | 192.3 | 120.03 |
Short-Term Debt | 216.6 | 503.43 | 535 | 614.57 | 805.17 |
Current Portion of Long-Term Debt | 8.24 | 33.08 | 22 | 16.01 | 48.34 |
Current Portion of Leases | 6.22 | 7.08 | 4.55 | 3.01 | 0.64 |
Current Income Taxes Payable | 4.42 | 22.63 | 110.2 | 11.34 | 4.65 |
Current Unearned Revenue | 85.58 | 100.29 | 73.8 | - | - |
Other Current Liabilities | 1,185 | 23.98 | 20.46 | 59.06 | 21.2 |
Total Current Liabilities | 1,852 | 1,022 | 1,099 | 896.29 | 1,000 |
Long-Term Debt | - | - | 33.08 | 8.33 | 24.36 |
Long-Term Leases | 66.2 | 47.89 | 44.36 | 28.28 | 24.7 |
Other Long-Term Liabilities | 0.52 | 2.39 | 26.93 | 25.89 | 14.86 |
Total Liabilities | 1,954 | 1,108 | 1,236 | 987 | 1,086 |
Common Stock | 246.43 | 246.43 | 187.3 | 187.3 | 50 |
Additional Paid-In Capital | 305.88 | 305.88 | 305.88 | 305.88 | - |
Retained Earnings | 225.81 | 993.46 | 575.48 | 103.91 | 98.34 |
Comprehensive Income & Other | -251.78 | -26.37 | -26.37 | -24.95 | 366.47 |
Total Common Equity | 526.34 | 1,519 | 1,042 | 572.14 | 514.81 |
Minority Interest | - | 0 | 0 | -0.93 | - |
Shareholders' Equity | 526.34 | 1,519 | 1,042 | 571.21 | 514.81 |
Total Liabilities & Equity | 2,481 | 2,627 | 2,278 | 1,558 | 1,601 |
Total Debt | 297.26 | 591.48 | 638.99 | 670.21 | 903.21 |
Net Cash (Debt) | -191.76 | -243.44 | -331.82 | -648.02 | -836.31 |
Net Cash Per Share | -0.60 | -0.88 | -1.33 | -8.98 | -12.54 |
Filing Date Shares Outstanding | 328.57 | 328.57 | 249.73 | 249.73 | 66.67 |
Total Common Shares Outstanding | 328.57 | 328.57 | 249.73 | 249.73 | 66.67 |
Working Capital | -633.72 | 428.98 | 126.89 | -280.97 | -300.37 |
Book Value Per Share | 1.60 | 4.62 | 4.17 | 2.29 | 7.72 |
Tangible Book Value | 492.9 | 1,494 | 1,030 | 570.91 | 514.54 |
Tangible Book Value Per Share | 1.50 | 4.55 | 4.12 | 2.29 | 7.72 |
Land | - | - | 94.16 | 64.95 | 64.95 |
Buildings | - | - | 897.56 | 713.66 | 672.08 |
Machinery | - | - | 448.73 | 415.39 | 378.1 |
Construction In Progress | - | - | 93.44 | 82.16 | 75.3 |
Source: S&P Capital IQ. Standard template. Financial Sources.